A new study reveals that nearly 7% of school-going children in India are obese, with alarming rates rising in the northern ...
India's obesity roundtable unites 40+ experts and policymakers in New Delhi to build a coordinated national response to ...
Obesity risk begins early—even before birth—driven by maternal BMI, formula feeding, poor diets, and family lifestyle. Early ...
Hosted on MSN
Rethinking healthy weight beyond the BMI chart
For decades, BMI has been the go-to tool for defining healthy weight, overweight, and obesity, but experts now say it’s not enough. New approaches consider waist size, fat distribution, and body ...
The carnivore diet is a high-protein, low-carbohydrate eating pattern that focuses on animal products such as fish, eggs, ...
After a phase of strong growth and margin expansion, Shaily Engineering Plastics is entering a more demanding phase. The ...
Dr Samantha Philip and Dr Kathryn E Kyler discuss the impact of weight bias in healthcare and ways for physicians to be more ...
A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight ...
Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...
Eli Lilly remains well-positioned in the obesity treatment market despite early script underperformance of Foundayo. Read ...
Everyday Health on MSN
Can GLP-1 drugs for obesity and diabetes also treat other diseases?
Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...
Lexicon Pharmaceuticals is back in focus as Street price targets now cluster in a wider band, roughly between US$2.30 and US$6.00 per share. This shift lines up with more constructive analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results